NCT03812419 - Esomeprazole or Pantoprazole in Renal Transplantation | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 5, 2016

Primary Completion Date

December 10, 2016

Study Completion Date

December 30, 2016

Conditions

Kidney Transplant; Complications

Interventions

DRUG

Esomeprazole 40 mg

Esomeprazole 40 mg In addition, the immunosuppressant combination of CsA (Sandimmune; Novartis, East Hanover, NJ, USA), MMF (Cellcept; Roche, Basel, Switzerland) and the corticosteroid prednisolone (Solupred; Sanofi Aventis, Tours, France).

DRUG

Pantoprazole 40mg

Pantoprazole 40 mg In addition, the immunosuppressant combination of CsA (Sandimmune; Novartis, East Hanover, NJ, USA), MMF (Cellcept; Roche, Basel, Switzerland) and the corticosteroid prednisolone (Solupred; Sanofi Aventis, Tours, France).

All Listed Sponsors

collaborator

Ain Shams University

OTHER

collaborator

Nasser Institute For Research and Treatment

OTHER_GOV

lead

Future University in Egypt

OTHER